Michael Angarone is an Infectious Disease physician affiliated with Northwestern University. OpenAlex indexes 81 publications with 1,539 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
676 N Saint Clair St
Suite 940
Chicago, IL 606112927
Telephone
312-926-8358Registry record last updated 13 Oct 2011.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20254 payments
- ViiV Healthcare CompanyProgram year20252 payments
- Gilead Sciences, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
68.9%Short-acting sulfonamides18.7%Sulfamethoxazole-Trimethoprim100%Part D≥21 patientsAntimycobacterial9.8%Isoniazid50%Ethambutol Hcl50%Part D<11 patients+ 7 more classes in this area
Respiratory
12.4%beta2-Adrenergic Agonist6.9%Albuterol Sulfate Hfa100%Part D<11 patientsOpioid Agonist5.5%Hydrocodone-Acetaminophen100%Part D<11 patientsCardiovascular
11.5%Calcium channel blocker4%Amlodipine Besylate100%Part D<11 patientsStatin3.7%Atorvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2024 - Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention
Current Opinion in Infectious Diseases
2024 - Mycobacteroides abscessus outbreak and mitigation in a cardiothoracic transplant population: the problem with tap water
Journal of Hospital Infection
2024 - A cluster of six respiratory cultures positive for Mycobacterium xenopi –Clinical characteristics and genomic characterization
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”